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Abstract
Background: The Share 35 policy was instituted in June 2013 by the United Network for Organ Sharing (UNOS) in
order to reduce death on liver transplant waiting list. The effect of this policy on racial and ethnic disparities in
access to liver transplantation has not been examined.
Methods: A total of 14,585 adult patients registered for liver transplantation between 2012 and 2015 were identified
from UNOS database. Logistic and proportional hazards models were used to model the effects of race and ethnicity
on access to liver transplantation. Stratification on pre- and post-Share 35 periods was performed to compare the first
18 months of Share 35 policy to an equivalent time period before.
Results: Comparison of the pre- and post-Share 35 periods showed significantly decreased time on waiting list and
increased numbers of minorities having access to liver transplantation. Hispanic recipients still experienced significantly
longer waiting time (HR: 0.69, 95% CI: 0.53–0.88) before they received liver transplantation after Share 35 policy took effect.
Conclusion: The Share 35 policy did not lead to improved access to liver transplantation among minorities but eliminated
the previously observed racial and ethnic disparities in transplant rates as well as shortened the waiting time.
Keywords: Racial and ethnic disparities, Liver transplantation, Share 35 policy, United Network for Organ Sharing
Background
According to the U.S. Census Bureau, the United States
is projected to become more racially and ethnically diverse
in the coming years [1]. Although the non-Hispanic White
is currently the majority group accounting for 62.2% of
the nation’s total population, the majority and minorities
(any group other than non-Hispanic White alone) cross-
over is estimated to occur in 2044 [1]. In addition, by
2060, 56% of all Americans are projected to belong to a
minority group [1]. The African American (AA) popula-
tion is expected to encompass 14.3% of the U.S.
population, while Hispanics will account for nearly 30% of
the U.S. population [1].
In the past decades, AAs have experienced higher
mortality rates from end-stage liver disease (ESLD) than
non-Hispanic whites, and this pattern has also been ob-
served more recently in Hispanics [2]. Data from Centers
for Disease Control and Prevention identified that mortal-
ity from ESLD in Hispanics in the U.S. was almost 50%
higher than in non-Hispanic whites (13.7 per 100,000 in
Hispanics vs 9.2 in non-Hispanic whites) [3]. As liver
transplantation being the only curative option for patients
with ESLD at present, more than 14,000 people in the
United States are currently waiting for liver transplant-
ation (7.7% being AAs and 17.8% Hispanics) [4]. However,
patients’ access to liver transplantation has been limited
because of the widening gap between the increasing
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number of transplantation candidates on the waiting list
and the number of available livers [5]. In addition, it has
been reported that AAs had significantly lower transplant
rates both in the eras prior and posterior to the adoption
of the Model for End-Stage Liver Disease (MELD) score
in 2002, a numeric scale ranging from 6 (less ill) to 40
(gravely ill) used for liver transplantation candidates age
12 and older to evaluate how urgently he or she needs a
liver transplantation within the next 3 months [6]. Recent
data also observed higher risks for developing alcohol-
related liver disease and higher MELD scores in minority
populations while waiting on the list, particularly among
AAs and Hispanics [2, 3, 7–9].
On June 18, 2013, the Share 35 policy was instituted
by the United Network for Organ Sharing (UNOS), a
private, non-profit organization that manages the na-
tion’s organ transplant system under contract with the
federal government [10]. The Share 35 policy mandates
that regional sharing of livers (livers distributed to the
11 UNOS allocation regions in the U.S.) for patients
with a MELD score of ≥ 35 is prioritized over local sharing
(livers distributed to candidates located in the same region
as the donor) to patients with a MELD score of < 35 in
order to reduce the waiting list mortality. Previous studies
have evaluated race and ethnic disparities on access to
liver transplantation but failed to adjust for geographic
factors that may affect the availability of livers from de-
ceased donors, and others failed to take the effect of Share
35 policy into account [11–14].
Therefore, given the rapid diversification of the U.S.
population, the growing burden of liver disease in minor-
ity communities, as well as the implementation of Share
35 policy, the objective of the paper was to address the im-
pact of the Share 35 policy on racial and ethnic differences
in access to liver transplantation by comparing the first
18 months of the initiation of the policy to an equivalent
time period before, using the UNOS database, while ac-
counting for patient differences and geographic factors.
Methods
Data source
Data were collected by each transplant center and trans-
mitted to UNOS. Detailed descriptions of the UNOS
registry have been published elsewhere [15]. Briefly, the
UNOS registry records and documents any change in
standard demographic, clinical, and laboratory information
available at the time of listing, during transplantation, and
post-transplantation, as well as information on the donors.
The UNOS data set contains one record per transplant-
ation event.
The committee for the Protection of Human Subjects
at the University of Texas Health Science Center at
Houston approved this study.
Study population
A total of 15,789 liver transplant candidates with ESLD,
18 years of age and older, with an initial data of registra-
tion for deceased donor liver transplantation between
January 1st, 2012 and March 31st, 2015 were identified
from the wait list and liver file of the UNOS database.
Only candidates with race/ethnicity defined as non-Hispanic
white, non-Hispanic AA, and Hispanic were selected
(n = 14,943). Patients with other races, more than one
races, unknown race were not included (n = 646, 4%)
due to small numbers. Candidates were then excluded
for the following reasons: missing Body Mass Index
(BMI) (n = 3), missing diagnosis (n = 6), unknown MELD
score at listing (n = 2), and unknown transplant center
(n = 347). After all exclusions, a total of 14,585 patients
were available for analysis (Fig. 1).
Study variables
The primary outcome, the access to liver transplantation,
was measured by 1): the receipt of liver transplantation,
and 2) the total time on the waiting list before the receipt
of liver transplantation in days.
The exposure variable of primary interest was race/
ethnicity as reported in UNOS records, classified as
non-Hispanic white, non-Hispanic AA, and Hispanic.
Other demographic and clinical variables included age at
listing in years, gender (male or female), BMI measured in
units of kg/m2, diagnosis, MELD score at listing, health in-
surance status, median household income in current dol-
lars, geographical region, and transplant center.
Follow-up for patients began when they were initially
added to the waiting list. Patients were then followed
until the earliest of liver transplantation, death, the grant-
ing of a MELD exception score, or the end of the study.
Patients who received a liver transplantation, alive, or lost
to follow-up were censored at the date of transplantation
or last follow-up.
Statistical analysis
Frequencies and percentages were calculated for the
baseline demographic and clinical characteristics. Chi-
square tests and ANOVA tests were used to compare the
characteristics among three racial and ethnical groups as
well as between pre-Share 35 and post-Share 35 periods.
Logistic regression models were used to model the effects
of race and ethnicity on the receipt of liver transplantation
adjusting for all other demographic and clinical character-
istics. Cox proportional hazards models were used to
model the effects of race and ethnicity on the total waiting
time on the list before the receipt of liver transplantation
in days adjusting for all other demographic and clinical
characteristics. To account for the impact of geographic
factors, regions or transplant centers were incorporated as
clusters in all regression models by a marginal approach
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with a working independence assumption. Stratifications
between pre-Share 35 period and post-Share 35 period
were also performed. All statistical analyses were per-
formed with SAS version 9.4 (SAS Institute Inc., Cary,
NC). P-values less than 0.05 were considered statistically
significant.
Results
The baseline demographic and clinical characteristics of
the 14,585 patients were displayed in Table 1. Compared
to the pre-Share 35 cohort, racial and ethnic subgroups
in the post-Share 35 cohort were similar with respect to
the following factors: age at wait-listing, gender, BMI at
listing, median household income, and health insurance
status. The mean time on waiting list decreased signifi-
cantly from 67 days to 32 days for AAs and from 107 days
to 40 days for Hispanics. Compared to pre-Share 35 period,
there were higher proportions of both AAs (87.0%) and
Hispanics (86.9%) in the post-Share 35 period receiving
liver transplantation. AA patients had lower proportions in
being on the waitlist (3.0%), being too sick to receive trans-
plantation (7.2%), having insurance issues (1.8%) and with-
drawn from waitlist (0.5%). Hispanic patients experienced
reduced proportions in being too sick to receive transplant-
ation (7.0%) and having insurance issues (1.1%). There
were significantly less patients with MELD score at listing
below 35 and more patients with MELD score greater than
35 registered on the waiting list for all the three racial and
ethnic subgroups after the implementation of the Share 35
policy.
Table 2 displayed the risk-adjusted odds ratios for liver
transplant rates among patients registered on waiting list
for both pre- and post-Share 35 periods. AA patients
were 11% more likely to receive liver transplantation
after the Share 35 policy took effect (OR: 1.11, 95% CI:
0.89–1.40), but the association was non-significant com-
pared to white patients. In contrast to AAs, Hispanics
had a significantly higher liver transplant rate (1.34,
1.11–1.63) versus whites during the pre-Share 35 period.
However, they did not have significantly different trans-
plant rates in comparison to whites (1.15, 0.94–1.41)
during post-Share 35 period.
The Cox proportional hazard regression results of the
waiting time before access to liver transplantation for
both pre- and post-Share 35 periods were presented in
Table 3. AA patients had to wait approximately 20% lon-
ger on the waiting list before receiving liver transplant-
ation compared to white patients (HR: 0.82, 95% CI,
0.61–0.88), and this situation did not improve after the
Share 35 policy (0.81, 0.60–1.10). On the other hand,
Hispanic patients experienced a significantly longer wait-
ing time to liver transplantation compared to white pa-
tients (0.66, 0.53–0.82), but they trended toward a slight
shorter waiting time (0.69, 0.53–0.88) due to the Share
35 policy.
Discussion
In the United States, minority patients account for approxi-
mately 30% of all adult liver transplantations performed
annually [8]. Racial and ethnic disparities in transplant-
ation have been framed as a combination of barriers in
access to care [16]. Overall, the study observed signifi-
cantly decreased time on waiting list and higher propor-
tion of patients listed with MELD scores over 35 after the
Share 35 policy. Subgroups of minority candidates no
longer had lower transplant rates than non-Hispanic
whites. Hispanics experienced shorter waiting time be-
fore the receipt of liver transplantation but still longer
than their white counterparts. To the best of knowledge,
this study was the first study to explore racial and ethnic
inequity in access to liver transplantation for patients with
ESLD after the Share 35 policy instituted in June 2013.
Previous disparity-related studies have only stratified on
Organ Procurement and Transplant Network (OPTN)
Fig. 1 Flowchart for inclusion and exclusion of study population
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regions and some even have not correctly adjusted for
geographic or transplant center factors that may affect the
receipt of liver transplantation [11, 17, 18]. Patients
treated within a hospital or transplant center tend to be
more alike, but the likelihood of receiving a liver
transplantation varies between transplant centers in differ-
ent parts of the country and is related to the local avail-
ability of deceased organ donors [14]. This violates the
heart of classical statistical estimation assumption that
treating patients as independent individuals. Geographic
variation has also been considered as a threat to delayed
access to specialized health care or has been directed to
limited local transplant facilities and hepatology expertise
[14]. Thus, failure to account for the dependence between
individual patients and the transplant centers to which
they belong can have profound implications such as falsely
narrow confidence intervals and falsely low p-values,
which means the risk of a false-positive result is increased
[19]. Our study went beyond the previous ones that a
carefully designed statistical marginal approach with a
working independence assumption was incorporated so
that each region or transplant center was treated as a clus-
ter in all regression models to account for the impact of
geographic variation and transplant center.
Table 1 Baseline demographic and clinical characteristics of waiting list candidates in the entire cohort by race and ethnicity:
Pre-Share 35 vs. Post-Share 35 time periods, 2012–2015
Pre-Share 35 (n = 7450) Post-Share 35 (n = 7135)
White (n = 5633) AA (n = 798) Hispanic (n = 1019) White (n = 5351) AA (n = 793) Hispanic (n = 991)
Age at listing (years), mean (SD) 57.0 (9.9) 57.0 (11.4) 56.0 (10.2) 58.0 (10.5) 57.0 (12.9) 56.0 (11.3)
Gender, n (%)
Male 3813 (67.7) 485 (60.8) 679 (66.6) 3603 (67.3) 462 (58.3) 648 (65.4)
Female 1820 (32.3) 313 (39.2) 340 (33.4) 1748 (32.7) 331 (41.7) 343 (34.6)
BMI, mean (SD) 27.9 (5.6) 27.5 (6.0) 27.7 (5.3) 27.9 (5.9) 27.5 (6.6) 28.3 (5.9)
Median household incomea 54269 43294 47143 54249 44723 46394
Time on waiting list (days), mean (SD) 92.0 (200.5) 67.0 (202.3) 107.0 (211.5) 53.0 (116.9) 32.0 (109.8) 40.0 (124.8)
Waiting list outcome, n (%)
Transplanted 4571 (81.2) 659 (82.6) 868 (85.2) 4550 (85.0) 690 (87.0) 861 (86.9)
Still waiting 233 (4.1) 26 (3.3) 36 (3.5) 163 (3.1) 24 (3.0) 35 (3.5)
Temporarily too sick 614 (10.9) 83 (10.4) 90 (8.8) 482 (9.0) 57 (7.2) 69 (7.0)
Insurance issues 88 (1.6) 18 (2.3) 13 (1.3) 69 (1.3) 14 (1.8) 11 (1.1)
Medical non-compliance 52 (0.9) 1 (0.1) 6 (0.6) 22 (0.4) 3 (0.4) 6 (0.6)
Candidate withdrawn 71 (1.3) 10 (1.3) 4 (0.4) 62 (1.2) 4 (0.5) 7 (0.7)
Candidate cannot be contacted 4 (0.1) 1 (0.1) 2 (0.2) 3 (0.1) 1 (0.1) 2 (0.2)
MELD at listing, n (%)
< 35 5158 (91.6) 697 (87.3) 886 (87.0) 4619 (86.3) 602 (75.9) 796 (80.3)
≥ 35 475 (8.4) 101 (12.7) 133 (13.0) 732 (13.7) 191 (24.1) 195 (19.7)
Health insurance status, n (%)
Private insurance 3301 (58.6) 382 (47.9) 454 (44.6) 3100 (57.9) 371 (46.8) 437 (44.1)
Public insurance 2292 (40.7) 405 (50.8) 552 (54.2) 2157 (40.3) 407 (51.3) 529 (53.4)
Self 21 (0.4) 7 (0.9) 5 (0.5) 19 (0.4) 1 (0.1) 4 (0.4)
Other 12 (0.2) 2 (0.3) 5 (0.5) 18 (0.3) 3 (0.4) 1 (0.1)
Unknown 7 (0.1) 2 (0.3) 3 (0.3) 57 (1.1) 11 (1.4) 20 (2.0)
AA African American, BMI body mass index, MELD model for end-stage liver disease
aSource: U.S. Census Bureau. Census tract level income in 2016 dollars
Table 2 Logistic regression results for the receipt of liver
transplantation among patients registered on waiting list:
Pre-Share 35 vs. Post-Share 35 time periods, 2012–2015





White 1.00 (reference) 1.00 (reference)
AA 1.09 (0.89–1.33) 1.11 (0.89–1.40)
Hispanic 1.34 (1.11–1.63) 1.15 (0.94–1.41)
AA African American, BMI body mass index, MELD model for end-stage
liver disease
aOdds ratios adjusted for age, gender, BMI, diagnosis, MELD score at listing,
median household income, and health insurance status
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For patients who were added to the UNOS waiting list,
studies in the pre-Share 35 era found significant racial
and ethnic differences in waiting list outcomes, as mea-
sured by death prior to transplantation or removal from
the waiting list due to being too sick for transplantation
[6, 20]. An important finding in our study was the lack
of overall disparities in transplant rates between ethnic
minorities and non-Hispanic whites, and in fact, there
appeared to be a slightly increase in the number of mi-
norities on waiting list and relatively stable percentages
of minorities who had access to liver transplantation.
AAs and Hispanics did present with more advanced dis-
ease at registration in comparison with whites, but equit-
able transplant rates were observed after accounting for
other demographic, clinical and geographic character-
istics. This finding was comparable to preliminary re-
sults of recent studies after Share 35 policy took effect
[11, 21–23]. Therefore, the implementation of Share
35 policy, with its emphasis on reducing mortality on
waiting list, did not lead to improved access to liver
transplantation so far but eliminated the previously ob-
served racial and ethnic disparity in waiting list.
Another notable finding in our study was that compared
to non-Hispanic white patients, AAs and Hispanics still
need to wait 20-40% more time before they received liver
transplantation, regardless of Share 35 policy. In previous
studies, delayed in access to liver transplantation were
found likely to result in higher MELD scores, more ad-
vanced disease, greater disease-related morbidity, impaired
access to quality pre-transplant care, and it may also be
associated with worse post-transplant outcomes [6, 8, 16].
One of the possible barriers behind the long waiting time
among minorities included the partly shortage of eligible
liver donors in the donor pool where the majority of
donors are white race [24], since there have already
been numerous studies highlighted the adverse impact
of donor and recipient race mismatch on post-transplant
outcomes among minorities [25–27]. Minority patients
therefore tend to face a dilemma situation, that is, either
to transplant with a racially mismatched donor in order to
shorten their time on waiting list but taking the risk of ad-
verse graft outcomes, or to wait for a racially matched
liver at the cost of increased MELD scores. This can be ac-
complished by encouraging more minority liver donors
into the donor pool.
Despite the racial and ethnic disparities alone, socio-
economic status and health insurance may also play crit-
ical roles in affecting the access to liver transplantation.
According to the National Healthcare Disparities Report,
health insurance was the key barrier to healthcare access
among AAs and Hispanics [28]. Our study emphasized
that AA and Hispanic patients were less likely to have
private insurance, but more likely to be insured by Me-
dicaid than white patients. Recent studies have docu-
mented a strong association between health insurance
status and the likelihood of registered for liver trans-
plantation [11, 29–32]. Insurance may alter a recipient’s
choice of a transplant center and increased the risk of
receiving liver transplantation with more severe liver
disease.
This study has limitations inherent to the retrospective
nature and lack of systematic data collection of the
UNOS database. Racial and ethnicity data were self-re-
ported, which was prone to misclassification bias. Sev-
eral studies measuring agreement between self-reported,
administrative measures, and phenotype-based information
for Medicaid enrollees or patients have shown incon-
sistency in reporting of race and ethnicity, particularly
for persons who self identified as Hispanic having greater
odds of being misclassified in administrative data [33–36].
Other races including Asian, American Indian/Alaska Na-
tive, Native Hawaiian/Other Pacific Islander, and multi-
races were not included in the study due to small numbers
of population. Also, health insurance status was the only
socioeconomic characteristic available in the UNOS
database at individual level that has been considered to
be associated with the access to liver transplantation.
Characteristic such as income was approximated by
median household income in current dollars at census
tract level, which may lose individual information.
However, due to the size of the database, the analysis of
the UNOS is so far the most possible and comprehen-
sive analysis of waiting list today.
Conclusion
In summary, determining whether racial and ethnic
disparities in access to liver transplantation exist is es-
sential. The differences found in our study present
challenges that contribute to the health disparities ob-
served in our diverse population. Comparison of the
pre- and post-Share 35 periods showed current racial
and ethnic variations in access to liver transplantation.
The findings of the study may serve as a reminder for
the future research of physicians and policy makers
Table 3 Cox proportional hazard regression results for the
waiting time before liver transplantation among patients
registered on waiting list: Pre-Share 35 vs. Post-Share 35 time
periods, 2012-2015





White 1.00 (reference) 1.00 (reference)
AA 0.82 (0.61–1.09) 0.81 (0.60–1.10)
Hispanic 0.66 (0.53–0.82) 0.69 (0.53–0.88)
AA African American, BMI body mass index, MELD model for end-stage
liver disease
aHazard ratios adjusted for age, gender, BMI, diagnosis, MELD score at listing,
median household income, and health insurance status
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who involved in the care of liver transplantation to ex-
plore quality improvement and other implementation
strategies to monitor and reduce disparities.
Abbreviations
BMI: Body mass index; ESLD: End stage liver disease; MELD: Model for end-stage
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